Product Liability Update

Collateral Source Rule Not Violated by References to Medical Insurance, Medicare and Social Security

Stokes v. Muschinske, No. B280116, 2019 WL 1513208 (Cal. Ct. App. Mar. 14, 2019) (awaiting official publication) begs the question, does reference to a plaintiff’s membership in a health care plan, like Kaiser Permanente, or Medicare eligibility violate the collateral source rule? The California Court of Appeal says not necessarily. In Stokes, the defendant was […]

May 14, 2019 | 4 min read

Sarah M. Nakamoto Associate

David P. Hansen Partner

Product Liability Litigation Group Ranked in 2019 “Best Law Firms”

Snell & Wilmer’s Product Liability Litigation Group achieved high rankings in 2019’s “Best Law Firms” by U.S. News Media Group and Best Lawyers®. We were ranked as a metropolitan area Tier 1 firm in Phoenix, Orange County, Colorado and Utah for product liability litigation defense. We were also ranked as a Tier 1 firm in […]

November 20, 2018 | 1 min read

Kelly Wilkins Former Partner

Location, Location, Location – A Brief Overview of Personal Jurisdiction, Forum Selection Clauses, and Why They Matter

Where a case is heard can make a critical difference to a company that is being sued. Will the company have the “home court” advantage and a jury that will know the company’s business, that the company employs people in the community and that it has a reputation for giving back to the community? Or […]

August 9, 2016 | 6 min read

Elisabeth M. McOmber Partner

Product Liability Litigation Group Ranked in 2016 “Best Law Firms”

Snell & Wilmer’s Product Liability Litigation Group achieved high rankings in “Best Law Firms” by U.S. News Media Group and Best Lawyers®. We were ranked as a metropolitan area Tier 1 firm in Phoenix, Colorado and Utah for product liability litigation defense. We were also ranked as a Tier 1 firm in Phoenix for mass […]

November 10, 2015 | 1 min read

Kelly Wilkins Former Partner

What’s The “Internet of Things” and What Are Its Legal Challenges?

The “Internet of Things” is the universe of smart devices that talk to the internet or to one another. The devices have unique identifiers and the ability to automatically transfer data over a network on their own, without human interaction. Some examples in the home include WiFi-connected home security systems, thermostats, cameras, refrigerators, and wearable technology. Some […]

January 5, 2015 | 3 min read

Kelly Wilkins Former Partner

Summary of FDA’s Final Guidance on Dear Health Care Provider Letters

At the beginning of this year, the Food and Drug Administration (FDA) issued its final guidance on the content and format of Dear Health Care Provider (DHCP) letters. DHCP letters are correspondence, often in the form of a mass mailing from the FDA or a manufacturer of a drug, intended to alert health care providers […]

April 23, 2014 | 3 min read

Daniel S. Wittenberg Partner

Drug and Device Manufacturers Beware: Comments Could Result in FDA Troubles

After appearing on CNBC television show Fast Money, the CEO of Aegerion Pharmaceuticals received a warning letter from the United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion. The agency asserted that comments made on the show constituted promotional speech and resulted in Aegerion’s cholesterol lowering drug, Juxtapid, being misbranded. According to […]

February 10, 2014 | 2 min read

Laura Waugh Former Proposals Specialist

Ten Things to Know About the New Unique Device Identifier Rule for Medical Devices

Reprinted with the permission of the Record Reporter, originally printed as “The Future of Medical Recalls” on November 15, 2013. Many medical devices will soon carry a unique identity code, under a new rule recently published by the U.S. Food and Drug Administration (FDA). The FDA refers to this as the Unique Device Identifier (UDI) rule. A […]

November 15, 2013 | 6 min read

Kelly Wilkins Former Partner

Ethics in Jury Selection: Responding to a Strike Challenge

Selecting a jury is one of the first and most critical parts of a trial. The goal of jury selection is to identify the prejudices and biases that may harm your client. The next step is to “de-select” and excuse, to the extent possible, those from the jury pool that hold those prejudices or biases. […]

March 25, 2013 | 3 min read

Timothy G. O'Neill Former Partner

Kelly Wilkins Former Partner